Interleukin-17: a mediator of inflammatory responses (original) (raw)

Abstract

Interleukin-17 (IL-17) is a prototype member of a new cytokine family with six species identified to date. IL-17 is secreted mainly by activated CD4+ and CD8+ T lymphocytes, while its receptor is distributed ubiquitously. IL-17 has been classified as a proinflammatory cytokine because of its ability to induce the expression of many mediators of inflammation, most strikingly those that are involved in the proliferation, maturation and chemotaxis of neutrophils. Increased levels of IL-17 have been associated with several conditions, including airway inflammation, rheumatoid arthritis, intraperitoneal abscesses and adhesions, inflammatory bowel disease, allograft rejection, psoriasis, cancer and multiple sclerosis. This review provides an overview of IL-17 activities, concentrating on those that lead to neutrophil recruitment.

Article PDF

Similar content being viewed by others

Author information

Authors and Affiliations

  1. Department of Pathophysiology, University Medical School, Święcickiego 6, 60-781, Poznań, Poland
    J. Witowski & K. Książek
  2. Department of Nephrology and Medical Intensive Care, Universitätsklinikum Charité, Berlin, Germany
    J. Witowski & A. Jörres

Authors

  1. J. Witowski
    You can also search for this author inPubMed Google Scholar
  2. K. Książek
    You can also search for this author inPubMed Google Scholar
  3. A. Jörres
    You can also search for this author inPubMed Google Scholar

Corresponding author

Correspondence toJ. Witowski.

Additional information

Received 13 June 2003; received after revision 27 August 2003; accepted 1 September 2003

Rights and permissions

About this article

Cite this article

Witowski, J., Książek, K. & Jörres, A. Interleukin-17: a mediator of inflammatory responses.CMLS, Cell. Mol. Life Sci. 61, 567–579 (2004). https://doi.org/10.1007/s00018-003-3228-z

Download citation